Risk Prediction and Management of BKPyV-DNAemia in Kidney Transplant Recipients: A Multicenter Analysis of Immunosuppressive Strategies

Risk Prediction and Management of BKPyV-DNAemia in Kidney Transplant Recipients: A Multicenter Analysis of Immunosuppressive Strategies

BK polyomavirus (BKPyV) DNAemia remains a major complication in kidney transplantation (KT), requiring nuanced adjustments to immunosuppressive regimens to control viral replication while minimizing rejection risk. This retrospective multicenter cohort study included 8,027 KT recipients, of whom 1,1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jin-Myung Kim, Hye Eun Kwon, Ahram Han, Youngmin Ko, Sung Shin, Young Hoon Kim, Kyo Won Lee, Jae Berm Park, Hyunwook Kwon, Sangil Min
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Transplant International
Subjects:	kidney transplantation Bk virus immunosuppressive therapy calcineurin inhibitor tacrolimus trough level
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14738/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018-02-01)

MEDICAMENTAL IMMUNOSUPRESSION IN EARLY AGE PEDIATRIC LIVER RECIPIENTS
by: S. V. Gautier, et al.
Published: (2012-09-01)

Transplant failure in relation to BK viremia status among kidney transplant recipients in Jordan
by: Rabaa Y. Athamneh, et al.
Published: (2025-07-01)

EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
by: E. I. Prokopenko
Published: (2010-06-01)

A presentation of posterior reversible encephalopathy syndrome after heart transplantation: a case report and review of literature
by: Daniel Grandmougin, et al.
Published: (2025-08-01)

Personalized dosing protocol for extended-release tacrolimus in kidney transplant recipients in the early postoperative period
by: A. V. Shabunin, et al.
Published: (2023-04-01)

Effect of tacrolimus formulation on neurocognition in older kidney transplant recipients: A randomized controlled trial
by: Hadia Lala Gul, et al.
Published: (2025-09-01)

Calcineurin–NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy
by: Kamila Bendickova, et al.
Published: (2017-06-01)

Analisa pentingnya aplikasi sistem database dalam sistem informasi manajemen bimbingan dan konseling
by: Asri Widyaningtyas, et al.
Published: (2021-06-01)

The Impact of BK Virus and Cytomegalovirus Infections on Graft in Renal Transplant Patients: Experience of a Tertiary Hospital in Turkey
by: Şükran KÖSE, et al.
Published: (2017-12-01)

Immunosuppressive drugs and their aerosol delivery for COVID-19 treatment
by: V. I. Kobylyansky
Published: (2022-10-01)

Using network toxicology and molecular docking to identify core targets and pathways underlying tacrolimus-induced tremor in organ transplant recipients
by: Chao Liu, et al.
Published: (2025-07-01)

Kit for diagnosis of BK virus infection by the real-time Polymerase Chain Reaction method (PCR)
by: K. L. Dziadziulia, et al.
Published: (2018-02-01)

Anti-Fibrotic Effect of Tacrolimus on Preventing Adhesion after Achilles Tendon Surgery in a Murine Model
by: Seyedeh Elnaz Nazari, et al.
Published: (2025-08-01)

Correlation between dietary salt intake and renal outcomes related to calcineurin inhibitor nephrotoxicity in kidney transplant recipients
by: Satoru Sanada, et al.
Published: (2025-07-01)

Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
by: N. Yu. Nikishina, et al.
Published: (2025-06-01)

Impact of CYP3A4 and ABCB1 genetic variants on tacrolimus dosing in Greek kidney transplant recipients
by: Anna Tsironi, et al.
Published: (2025-03-01)

Uso de pomada de tacrolimus al 0,1% durante un año en niños con vitiligo
by: Rosa Feltes, et al.
Published: (2019-03-01)

Development of transplant-acquired multiple food allergies: a case series
by: Ümmügülsüm Dikici, et al.
Published: (2024-02-01)

First‐In‐Human, Randomized, Placebo‐Controlled, SAD and MAD Trial to Evaluate Safety, Tolerability, and PK/PD Modeling of Potravitug in Healthy Adults
by: Marcus May, et al.
Published: (2025-08-01)

Clinical efficacy of tacrolimus combined with glucocorticoids for idiopathic membranous nephropathy
by: LING Yi-sheng, et al.
Published: (2016-01-01)

IMMUNOSUPRESSION MINIMIZATION IN KIDNEY TRANSPLANTATION
by: O. N. Reznik, et al.
Published: (2011-12-01)

The value of pimecrolimus in improving quality of life of children with severe eczema — an open non-randomised study
by: Omolemo Kitchin, et al.
Published: (2010-02-01)

ON THE MODULAR SEQUENCE SPACES GENERATED BY THE CESÀRO MEAN
by: Sukhdev Singh, et al.
Published: (2024-12-01)

Renal function in liver recipients: in-depth analysis of data from the Local Scientific Transplant Registry of the Burnasyan Federal Medical Biophysical Center
by: A. I. Sushkov, et al.
Published: (2025-06-01)

Higher induction and maintenance infliximab trough levels are associated with radiological perianal fistula healing in pediatric patients with Crohn's disease
by: Joonhyuk Son, et al.
Published: (2025-05-01)

A retrospective study of calcineurin inhibitors in the treatment of idiopathic membranous nephropathy
by: CUI Lin-lin, et al.
Published: (2015-01-01)

A controlled clinical study of efficacy of different treatment regimens for idiopathic membranous nephropathy
by: LUO Man-yu, et al.
Published: (2019-01-01)

Early Determination of Tacrolimus Concentration–Dose Ratio Identifies Risk of Allograft Loss in Kidney Transplantation
by: Christophe Masset, et al.
Published: (2025-05-01)

The Safety and Effectiveness of 0.03% Tacrolimus in Pediatric Patients Presenting with Vernal Keratoconjunctivitis in Children Hospital, Multan
by: Muhammad Ajmal Chaudhary, et al.
Published: (2025-01-01)

THE USE OF EVEROLIMUS IN KIDNEY TRANSPLANTATION FROM EXPANDED CRITERIA DONORS
by: I. V. Ulyankina, et al.
Published: (2009-06-01)

Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023
by: Saleh F. Alqifari, et al.
Published: (2025-07-01)

Single-nucleotide polymorphisms within the BK polyomavirus non-coding control region are genotype-associated
by: Tiana A. Walder, et al.
Published: (2025-08-01)

BK channel activity in skin fibroblasts from patients with neurological disorder
by: Ria L. Dinsdale, et al.
Published: (2025-12-01)

Tacrolimus eye drops treatment for recurrent exposure of the Ahmed glaucoma valve tube
by: Li-Li Chen, et al.
Published: (2025-07-01)

Effect of genetic polymorphism on individualized treatment of tacrolimus in patients with primary nephrotic syndrome
by: Xiong Lian-lian, et al.
Published: (2021-01-01)

Efficacy of tacrolimus or cyclophosphamide combined with glucocorticoids in the treatment of idiopathic membranous nephropathy
by: MAO Wen-li, et al.
Published: (2018-01-01)

Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice
by: Susanna M. Kannenberg, et al.
Published: (2020-11-01)

Granulomatous variant rosacea. Patients treatment experience
by: Yulia A. Gallyamova
Published: (2025-03-01)

Rescuing vascular dysfunction in dorsal pancreatic arteries prevents tacrolimus-induced glucose metabolism disorder in mice
by: Lingyan Fei, et al.
Published: (2025-06-01)